DDrare: Database of Drug Development for Rare Diseases

Repaglinide and insulin (DrugBank: Repaglinide)

3 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	0
21	Mitochondrial disease	0
299	Cystic fibrosis	1

6. Parkinson disease [ 2,123 clinical trials, 2,046 drugs, (DrugBank: 324 drugs), 183 drug target genes, 198 drug target pathways]

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 2,123 trial found

21. Mitochondrial disease [ 23 clinical trials, 29 drugs, (DrugBank: 28 drugs), 44 drug target genes, 65 drug target pathways]

Searched query = "Mitochondrial disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 23 trial found

299. Cystic fibrosis [ 1,592 clinical trials, 1,539 drugs, (DrugBank: 255 drugs), 81 drug target genes, 162 drug target pathways]

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 1,592 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00231192 (ClinicalTrials.gov)	October 2005	3/10/2005	Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes	Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes	Diabetes	Drug: Repaglinide and Insulin	Children's Hospital of Philadelphia	NULL	Withdrawn	12 Years	20 Years	Both	0	N/A	United States